Amit M. Yen T.C. Liao C.T. Chaturvedi P. Agarwal J.P. Kowalski L.P. Ebrahimi A. Clark J.R. Kreppel M. Zöller J. Fridman E. Bolzoni V.A. Shah J.P. Binenbaum Y. Patel S.G. Gil Z. International Consortium for Outcome Research (ICOR) in Head and Neck Cancer

Improvement in survival of patients with oral cavity squamous cell carcinoma: an international collaborative study.

Cancer. 119: 4242-4248https://doi.org/10.1002/cncr.28357Ord R.A. Isaiah A. Dyalram D. Lubek J.E.

Is long-term follow-up mandatory for stage I oral tongue cancer?.

J Oral Maxillofac Surg. 76: 2676-2683https://doi.org/10.1016/j.joms.2018.06.169Jerjes W. Upile T. Petrie A. Riskalla A. Hamdoon Z. Vourvachis M. Karavidas K. Jay A. Sandison A. Thomas G.J.

Clinicopathological parameters, recurrence, locoregional and distant metastasis in 115 T1–T2 oral squamous cell carcinoma patients.

Head Neck Oncol. 2: 9Camisasca D.R. Silami M.A. Honorato J. Dias F.L. de Faria P.A. Lourenço S.Q.

Oral squamous cell carcinoma: clinicopathological features in patients with and without recurrence.

ORL J Otorhinolaryngol Relat Spec. 73: 170-176https://doi.org/10.1159/000328340Wang B. Zhang S. Yue K. Wang X.D.

The recurrence and survival of oral squamous cell carcinoma: a report of 275 cases.

Chin J Cancer. 32: 614-618https://doi.org/10.5732/cjc.012.10219da Silva J.L. Cardoso Nunes N.C. Izetti P. de Mesquita G.G. de Melo A.C.

Triple negative breast cancer: a thorough review of biomarkers.

Crit Rev Oncol Hematol. 145102855https://doi.org/10.1016/j.critrevonc.2019.102855Hatakeyama S. Yoneyama T. Tobisawa Y. Ohyama C.

Recent progress and perspectives on prostate cancer biomarkers.

Int J Clin Oncol. 22: 214-221https://doi.org/10.1007/s10147-016-1049-y

BRAF mutation: current and future clinical pathological applications in colorectal carcinoma.

Histol Histopathol. 34: 469-477https://doi.org/10.14670/HH-18-079Ung L. Lam A.K. Morris D.L. Chua T.C.

Tissue-based biomarkers predicting outcomes in metastatic colorectal cancer: a review.

Clin Transl Oncol. 16: 425-435https://doi.org/10.1007/s12094-013-1154-6Ferris R.L. Blumenschein G. Fayette J. Guigay J. Colevas A.D. Licitra L. Harrington K. Kasper S. Vokes E.E. Even C. Worden F. Saba N.F. Iglesias Docampo L.C. Haddad R. Rordorf T. Kiyota N. Tahara M. Monga M. Lynch M. Geese W.J. Kopit J. Shaw J.W. Gillison M.L.

Nivolumab for recurrent squamous-cell carcinoma of the head and neck.

N Engl J Med. 375: 1856-1867https://doi.org/10.1056/NEJMoa1602252Rubin Grandis J. Melhem M.F. Gooding W.E. Day R. Holst V.A. Wagener M.M. Drenning S.D. Tweardy D.J.

Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival.

J Natl Cancer Inst. 90: 824-832https://doi.org/10.1093/jnci/90.11.824Ang K.K. Harris J. Wheeler R. Weber R. Rosenthal D.I. Nguyen-Tân P.F. Westra W.H. Chung C.H. Jordan R.C. Lu C.

Human papillomavirus and survival of patients with oropharyngeal cancer.

N Engl J Med. 363: 24-35https://doi.org/10.1056/NEJMoa0912217Shaikh M.H. Khan A.I. Sadat A. Chowdhury A.H. Jinnah S.A. Gopalan V. Lam A.K. Clarke D.T.W. McMillan N.A.J. Johnson N.W.

Prevalence and types of high-risk human papillomaviruses in head and neck cancers from Bangladesh.

BMC Cancer. 17: 792https://doi.org/10.1186/s12885-017-3789-0Arantes L.M.R.B. De Carvalho A.C. Melendez M.E. Lopes Carvalho A.

Serum, plasma and saliva biomarkers for head and neck cancer.

Expert Rev Mol Diagn. 18: 85-112https://doi.org/10.1080/14737159.2017.1404906Payne K. Brooks J. Spruce R. Batis N. Taylor G. Nankivell P. Mehanna H.

Circulating tumour cell biomarkers in head and neck cancer: current progress and future prospects.

Cancers (Basel). 11: 1115https://doi.org/10.3390/cancers11081115

Liquid biopsy in head and neck cancer: promises and challenges.

J Dent Res. 97: 701-708https://doi.org/10.1177/0022034518762071Alix-Panabières C. Pantel K.

Characterization of single circulating tumor cells.

FEBS Lett. 591: 2241-2250https://doi.org/10.1002/1873-3468.12662Chen J. Ye C. Dong J. Cao S. Hu Y. Situ B. Xi X. Qin S. Xu J. Cai Z. Zheng L. Wang Q.

Metabolic classification of circulating tumor cells as a biomarker for metastasis and prognosis in breast cancer.

J Transl Med. 18: 59https://doi.org/10.1186/s12967-020-02237-8

The biology of circulating tumor cells.

Oncogene. 35: 1216https://doi.org/10.1038/onc.2015.192Dianat-Moghadam H. Azizi M. Eslami-S Z. Cortés-Hernández L.E. Heidarifard M. Nouri M. Alix-Panabières C.

The role of circulating tumor cells in the metastatic cascade: biology, technical challenges, and clinical relevance.

Cancers (Basel). 12: 867https://doi.org/10.3390/cancers12040867Aceto N. Bardia A. Miyamoto D.T. Donaldson M.C. Wittner B.S. Spencer J.A. Yu M. Pely A. Engstrom A. Zhu H. Brannigan B.W. Kapur R. Stott S.L. Shioda T. Ramaswamy S. Ting D.T. Lin C.P. Toner M. Haber D.A. Maheswaran S.

Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis.

Cell. 158: 1110-1122https://doi.org/10.1016/j.cell.2014.07.013Luo Y.T. Cheng J. Feng X. He S.J. Wang Y.W. Huang Q.

The viable circulating tumor cells with cancer stem cells feature, where is the way out?.

J Exp Clin Cancer Res. 37: 38https://doi.org/10.1186/s13046-018-0685-7Pantel K. Alix-Panabières C.

Liquid biopsy and minimal residual disease—latest advances and implications for cure.

Nat Rev Clin Oncol. 16: 409-424https://doi.org/10.1038/s41571-019-0187-3Thery L. Meddis A. Cabel L. Proudhon C. Latouche A. Pierga J.Y. Bidard F.C.

Circulating tumor cells in early breast cancer.

JNCI cancer spectrum. 3pkz026https://doi.org/10.1093/jncics/pkz026Doyen J. Alix-Panabières C. Hofman P. Parks S.K. Chamorey E. Naman H. Hannoun-Lévi J.M.

Circulating tumor cells in prostate cancer: a potential surrogate marker of survival.

Crit Rev Oncol Hematol. 81: 241-256https://doi.org/10.1016/j.critrevonc.2011.05.004Syrigos K. Fiste O. Charpidou A. Grapsa D.

Circulating tumor cells count as a predictor of survival in lung cancer.

Crit Rev Oncol Hematol. 125: 60-68https://doi.org/10.1016/j.critrevonc.2018.03.004Lu Y.J. Wang P. Peng J. Wang X. Zhu Y.W. Shen N.

Meta-analysis reveals the prognostic value of circulating tumour cells detected in the peripheral blood in patients with non-metastatic colorectal cancer.

Sci Rep. 7: 905https://doi.org/10.1038/s41598-017-01066-yBork U. Rahbari N.N. Schölch S. Reissfelder C. Kahlert C. Büchler M.W. Weitz J. Koch M.

Circulating tumour cells and outcome in non-metastatic colorectal cancer: a prospective study.

Br J Cancer. 112: 1306-1313https://doi.org/10.1038/bjc.2015.88Jatana K.R. Balasubramanian P. McMullen K.P. Lang J.C. Teknos T.N. Chalmers J.J.

Effect of surgical intervention on circulating tumor cells in patients with squamous cell carcinoma of the head and neck using a negative enrichment technology.

Head Neck. 38: 1799-1803https://doi.org/10.1002/hed.24519

Limits of tumor detectability in nuclear medicine and PET.

Mol Imaging Radionucl Ther. 21: 23-28https://doi.org/10.4274/Mirt.138Budd G.T. Cristofanilli M. Ellis M.J. Stopeck A. Borden E. Miller M.C. Matera J. Repollet M. Doyle G.V. Terstappen L.W.M.M. Hayes D.F.

Circulating tumor cells versus imaging—predicting overall survival in metastatic breast cancer.

Clin Cancer Res. 12: 6403-6409https://doi.org/10.1158/1078-0432.CCR-05-1769Goddard E.T. Bozic I. Riddell S.R. Ghajar C.M.

Dormant tumour cells, their niches and the influence of immunity.

Nat Cell Biol. 20: 1240-1249https://doi.org/10.1038/s41556-018-0214-0Kim K. Marquez-Palencia M. Malladi S.

Metastatic latency, a veiled threat.

Front Immunol. 10: 1836https://doi.org/10.3389/fimmu.2019.01836Harper K.L. Sosa M.S. Entenberg D. Hosseini H. Cheung J.F. Nobre R. Avivar-Valderas A. Nagi C. Girnius N. Davis R.J.

Mechanism of early dissemination and metastasis in Her2+ mammary cancer.

Nature. 540: 588-592https://doi.org/10.1038/nature20609Hosseini H. Obradović M.M.S. Hoffmann M. Harper K.L. Sosa M.S. Werner-Klein M. Nanduri L.K. Werno C. Ehrl C. Maneck M.

Early dissemination seeds metastasis in breast cancer.

Nature. 540: 552-558https://doi.org/10.1038/nature20785

Parallel progression of primary tumours and metastases.

Nat Rev Cancer. 9: 302-312https://doi.org/10.1038/nrc2627

Parallel progression of tumour and metastases.

Nat Rev Cancer. 10 ()https://doi.org/10.1038/nrc2627-c1Riethdorf S. Fritsche H. Müller V. Rau T. Schindlbeck C. Rack B. Janni W. Coith C. Beck K. Jänicke F. Jackson S. Gornet T. Cristofanilli M. Pantel K.

Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system.

Clin Cancer Res. 13: 920-928https://doi.org/10.1158/1078-0432.CCR-06-1695Pantel K. Alix-Panabières C. Riethdorf S.

Cancer micrometastases.

Nat Rev Clin Oncol. 6: 339-351https://doi.org/10.1038/nrclinonc.2009.44Keller L. Werner S. Pantel K.

Biology and clinical relevance of EpCAM.

Cell Stress. 3: 165-180https://doi.org/10.15698/cst2019.06.188Gires O. Pan M. Schinke H. Canis M. Baeuerle P.A.

Expression and function of epithelial cell adhesion molecule EpCAM: where are we after 40 years?.

Cancer Metastasis Rev. 39: 969-987https://doi.org/10.1007/s10555-020-09898-3

Expression of epithelial cell adhesion molecule (EpCAM) in oral squamous cell carcinoma.

Histopathology. 68: 897-904https://doi.org/10.1111/his.12870Herreros-Pomares A. Aguilar-Gallardo C. Calabuig-Fariñas S. Sirera R. Jantus-Lewintre E. Camps C.

EpCAM duality becomes this molecule in a new Dr. Jekyll and Mr. Hyde tale.

Crit Rev Oncol Hematol. 126: 52-63https://doi.org/10.1016/j.critrevonc.2018.03.006Wang Z. Cui K. Xue Y. Tong F. Li S.

Prognostic value of circulating tumor cells in patients with squamous cell carcinoma of the head and neck: a systematic review and meta-analysis.

Med Oncol. 32: 164https://doi.org/10.1007/s12032-015-0579-xWu X.L. Tu Q. Faure G. Gallet P. Kohler C. Bittencourt M.C.

Diagnostic and prognostic value of circulating tumor cells in head and neck squamous cell carcinoma: a systematic review and meta-analysis.

Sci Rep. 6: 20210https://doi.org/10.1038/srep20210Cho J.K. Lee G.J. Kim H.D. Moon U.Y. Kim M.J. Kim S. Baek K.H. Jeong H.S.

Differential impact of circulating tumor cells on disease recurrence and survivals in patients with head and neck squamous cell carcinomas: an updated meta-analysis.

PLoS One. 13e0203758https://doi.org/10.1371/journal.pone.0203758Lauritano D. Oberti L. Gabrione F. Lucchese A. Petruzzi M. Carinci F. Lo Muzio L.

Liquid biopsy in head and neck squamous cell carcinoma: prognostic significance of circulating tumor cells and circulating tumor DNA. A systematic review.

Oral Oncol. 97: 7-17https://doi.org/10.1016/j.oraloncology.2019.07.003Partridge M. Brakenhoff R. Phillips E. Ali K. Francis R. Hooper R. Lavery K. Brown A. Langdon J.

Detection of rare disseminated tumor cells identifies head and neck cancer patients at risk of treatment failure.

Clin Cancer Res. 9: 5287Zen H. Nakashiro K.I. Shintani S. Sumida T. Aramoto T. Hamakawa H.

Detection of circulating cancer cells in human oral squamous cell carcinoma.

Int J Oncol. 23: 605-610Gröbe A. Blessmann M. Hanken H. Friedrich R.E. Schön G. Wikner J. Effenberger K.E. Kluwe L. Heiland M. Pantel K. Riethdorf S.

Prognostic relevance of circulating tumor cells in blood and disseminated tumor cells in bone marrow of patients with squamous cell carcinoma of the oral cavity.

Clin Cancer Res. 20: 425-433https://doi.org/10.1158/1078-0432.CCR-13-1101Brakenhoff R.H. Stroomer J.G. ten Brink C. de Bree R. Weima S.M. Snow G.B. van Dongen G.A.

Sensitive detection of squamous cells in bone marrow and blood of head and neck cancer patients by E48 reverse transcriptase-polymerase chain reaction.

Clin Cancer Res. 5: 725-732Wirtschafter A. Benninger M.S. Moss T.J. Umiel T. Blazoff K. Worsham M.J.

Micrometastatic tumor detection in patients with head and neck cancer: a preliminary report.

Arch Otolaryngol Head Neck Surg. 128: 40-43Jatana K.R. Balasubramanian P. Lang J.C. Yang L. Jatana C.A. White E. Agrawal A. Ozer E. Schuller D.E. Teknos T.N.

Significance of circulating tumor cells in patients with squamous cell carcinoma of the head and neck: initial results.

Arch Otolaryngol Head Neck Surg. 136: 1274-1279Hristozova T. Konschak R. Stromberger C. Fusi A. Liu Z. Weichert W. Stenzinger A. Budach V. Keilholz U. Tinhofer I.

The presence of circulating tumor cells (CTCs) correlates with lymph node metastasis in nonresectable squamous cell carcinoma of the head and neck region (SCCHN).

Ann Oncol. 22: 1878-1885https://doi.org/10.1093/annonc/mdr130Balasubramanian P. Lang J.C. Jatana K.R. Miller B. Ozer E. Old M. Schuller D.E. Agrawal A. Teknos T.N. Summers T.A. Lustberg M.B. Zborowski M. Chalmers J.J.

Multiparameter analysis, including EMT markers, on negatively enriched blood samples from patients with squamous cell carcinoma of the head and neck.

PLoS One. 7e42048https://doi.org/10.1371/journal.pone.0042048Buglione M. Grisanti S. Almici C. Mangoni M. Polli C. Consoli F. Verardi R. Costa L. Paiar F. Pasinetti N. Bolzoni A. Marini M. Simoncini E. Nicolai P. Biti G. Magrini S.M.

Circulating tumour cells in locally advanced head and neck cancer: preliminary report about their possible role in predicting response to non-surgical treatment and survival.

Eur J Cancer. 48: 3019-3026https://doi.org/10.1016/j.ejca.2012.05.007Tinhofer I. Konschak R. Stromberger C. Raguse J.D. Dreyer J.H. Jöhrens K. Keilholz U. Budach V.

Detection of circulating tumor cells for prediction of recurrence after adjuvant chemoradiation in locally advanced squamous cell carcinoma of the head and neck.

Ann Oncol. 25: 2042-2047https://doi.org/10.1093/annonc/mdu271Weller P. Nel I. Hassenkamp P. Gauler T. Schlueter A. Lang S. Dountsop P. Hoffmann A.C. Lehnerdt G.

Detection of circulating tumor cell subpopulations in patients with head and neck squamous cell carcinoma (HNSCC).

PLoS One. 9e113706https://doi.org/10.1371/journal.pone.0113706Kawada T. Takahashi H. Sakakura K. Ida S. Mito I. Toyoda M. Chikamatsu K.

Circulating tumor cells in patients with head and neck squamous cell carcinoma: feasibility of detection and quantitation.

Head Neck. 39: 2180-2186https://doi.org/10.1002/hed.24893Wu X. Mastronicola R. Tu Q. Faure Gc De Carvalho Bittencourt M. Dolivet G.

A rare case of extremely high counts of circulating tumor cells detected in a patient with an oral squamous cell carcinoma.

BMC Cancer. 16: 552https://doi.org/10.1186/s12885-016-2591-8

Screening for circulating tumour cells allows early detection of cancer and monitoring of treatment effectiveness: an observational study.

Asian Pac J Cancer Prev. 18: 2275-2285https://doi.org/10.22034/APJCP.2017.18.8.2275Partridge M. Phillips E. Francis R. Li S.R.

Immunomagnetic separation for enrichment and sensitive detection of disseminated tumour cells in patients with head and neck SCC.

J Pathol. 189: 368-377Guney K. Yoldas B. Ozbilim G. Derin A.T. Sarihan S. Balkan E.

Detection of micrometastatic tumor cells in head and neck squamous cell carcinoma. A possible predictor of recurrences.

Saudi Med J. 28: 216-220Winter S.C. Stephenson S.A. Subramaniam S.K. Paleri V. Ha K. Marnane C. Krishnan S. Rees G.

Long term survival following the detection of circulating tumour cells in head and neck squamous cell carcinoma.

BMC Cancer. 9: 424https://doi.org/10.1186/1471-2407-9-424Yang L. Lang J.C. Balasubramanian P. Jatana K.R. Schuller D. Agrawal A. Zborowski M. Chalmers J.J.

Optimization of an enrichment process for circulating tumor cells from the blood of head and neck cancer patients through depletion of normal cells.

Biotechnol Bioeng. 102: 521-534https://doi.org/10.1002/bit.22066Wang X. Qian X. Beitler J.J. Chen Z.G. Khuri F.R. Lewis M.M. Shin H.J. Nie S. Shin D.M.

Detection of circulating tumor cells in human peripheral blood using surface-enhanced Raman scattering nanoparticles.

Cancer Res. 71: 1526-1532https://doi.org/10.1158/0008-5472.CAN-10-3069Nichols A.C. Lowes L.E. Szeto C.C.T. Basmaji J. Dhaliwal S. Chapeskie C. Todorovic B. Read N. Venkatesan V. Hammond A.

Detection of circulating tumor cells in advanced head and neck cancer using the CellSearch system.

Head Neck. 34: 1440-1444Bozec A. Ilie M. Dassonville O. Long E. Poissonnet G. Santini J. Chamorey E. Ettaiche M. Chauvière D. Peyrade F. Hebert C. Benezery K. Sudaka A. Haudebourg J. Selva E. Hofman P.

Significance of circulating tumor cell detection using the CellSearch system in patients with locally advanced head and neck squamous cell carcinoma.

Eur Arch Otorhinolaryngol. 270: 2745-2749https://doi.org/10.1007/s00405-013-2399-yGrisanti S. Almici C. Consoli F. Buglione M. Verardi R. Bolzoni-Villaret A. Bianchetti A. Ciccarese C. Mangoni M. Ferrari L.

Circulating tumor cells in patients with recurrent or metastatic head and neck carcinoma: prognostic and predictive significance.

PLoS One. 9https://doi.org/10.1371/journal.pone.0103918Inhestern J. Oertel K. Stemmann V. Schmalenberg H. Dietz A. Rotter N. Veit J. Görner M. Sudhoff H. Junghanß C. Wittekindt C. Pachmann K. Guntinas-Lichius O.

Prognostic role of circulating tumor cells during induction chemotherapy followed by curative surgery combined with postoperative radiotherapy in patients with locally advanced oral and oropharyngeal squamous cell cancer.

PLoS One. 10e0132901https://doi.org/10.1371/journal.pone.0132901Hsieh J.C. Lin H.C. Huang C.Y. Hsu H.L. Wu T.M. Lee C.L. Chen M.C. Wang H.M. Tseng C.P.

Prognostic value of circulating tumor cells with podoplanin expression in patients with locally advanced or metastatic head and neck squamous cell carcinoma.

Head Neck. 37: 1448-1455https://doi.org/10.1002/hed.23779Kulasinghe A. Kenny L. Perry C. Thiery J.P. Jovanovic L. Vela I. Nelson C. Punyadeera C.

Impact of label-free technologies in head and neck cancer circulating tumour cells.

Oncotarget. 7: 71223-71234https://doi.org/10.18632/oncotarget.12086Fanelli M.F. Oliveira T.B. Braun A.C. Corassa M. Abdallah E.A. Nicolau U.R. da Silva Alves V. Garcia D. Calsavara V.F. Kowalski L.P.

Evaluation of incidence, significance, and prognostic role of circulating tumor microemboli and transforming growth factor‐β receptor I in head and neck cancer.

Head Neck. 39: 2283-2292Chang P.H. Wu M.H. Liu S.Y. Wang H.M. Huang W.K. Liao C.T. Yen T.C. Ng S.H. Chen J.S. Lin Y.C. Lin H.C. Hsieh J.C.

The prognostic roles of pretreatment circulating tumor cells, circulating cancer stem-like cells, and programmed cell death-1 expression on peripheral lymphocytes in patients with initially unresectable, recurrent or metastatic head and neck cancer: an exploratory study of three biomarkers in one-time blood drawing.

Cancers (Basel). 11https://doi.org/10.3390/cancers11040540

Detection of circulating tumor cells after surgery for stage III and IV squamous cell carcinoma of the head and neck.

J Transl Sci. 5: 1-5https://doi.org/10.15761/JTS.1000335Morgan T.M. Wang X. Qian X. Switchenko J.M. Nie S. Patel K.R. Cassidy R.J. Shin D.M. Beitler J.J.

Measurement of circulating tumor cells in squamous cell carcinoma of the head and neck and patient outcomes.

Clin Transl Oncol. 21: 342-347https://doi.org/10.1007/s12094-018-1930-4Wang H.M. Wu M.H. Chang P.H. Lin H.C. Liao C.D. Wu S.M. Hung T.M. Lin C.Y. Chang T.C. Tzu-Tsen Y. Hsieh J.C.

The change in circulating tumor cells before and during concurrent chemoradiotherapy is associated with survival in patients with locally advanced head and neck cancer.

Head Neck. 41: 2676-2687https://doi.org/10.1002/hed.25744Gorges T.M. Tinhofer I. Drosch M. Röse L. Zollner T.M. Krahn T. von Ahsen O.

Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition.

BMC Cancer. 12: 178https://doi.org/10.1186/1471-2407-12-178

Breast cancer: circulating and dynamic EMT.

Nat Rev Cancer. 13: 148https://doi.org/10.1038/nrc3475Zhao R. Cai Z. Li S.